Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells.
暂无分享,去创建一个
J Philip McCoy | J. P. McCoy | Hisayuki Yokoyama | Elena Cherkasova | N. Geller | R. Srinivasan | M. Lerman | S. Kajigaya | R. Childs | Yoshiyuki Takahashi | R. Kurlander | A. Tawab | A. Lundqvist | N. Harashima | Hisayuki Yokoyama | E. Cherkasova | K. Hanada | Othon Mena | Elizabeth B. Malinzak | Ramaprasad Srinivasan | Andreas Lundqvist | Michael I Lerman | Yoshiyuki Takahashi | Nancy Geller | Nanae Harashima | Sachiko Kajigaya | Ken-Ichi Hanada | Othon Mena | Roger Kurlander | Abdul Tawab | Elizabeth Malinzak | Richard W Childs | M. I. Lerman | J. P. Mccoy | Tawab Abdul | J. P. Mccoy
[1] J. Yang,et al. Identification of fibroblast growth factor-5 as an overexpressed antigen in multiple human adenocarcinomas. , 2001, Cancer research.
[2] S. Depil,et al. Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients , 2002, Leukemia.
[3] R. Kurth,et al. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[4] A. Greenwood,et al. Comprehensive Analysis of Human Endogenous Retrovirus Transcriptional Activity in Human Tissues with a Retrovirus-Specific Microarray , 2005, Journal of Virology.
[5] R. Kurth,et al. Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. , 2005, Cancer research.
[6] R. Parker,et al. Histologic Predictors of Renal Cell Carcinoma Response to Interleukin-2-Based Therapy , 2005, Journal of immunotherapy.
[7] David J Griffiths,et al. Endogenous retroviruses in the human genome sequence , 2001, Genome Biology.
[8] W. Linehan,et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. , 2000, The New England journal of medicine.
[9] A Sette,et al. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. , 1996, Immunology today.
[10] H. Pehamberger,et al. An endogenous retrovirus derived from human melanoma cells. , 2003, Cancer research.
[11] G. M. Ortiz,et al. Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma. , 2006, AIDS research and human retroviruses.
[12] M. Leppert,et al. Allogeneic Hematopoietic Cell Transplantation for Metastatic Renal Cell Carcinoma after Nonmyeloablative Conditioning , 2004, Clinical Cancer Research.
[13] N. Ueno,et al. The Second International Meeting on Allogeneic Transplantation in Solid Tumors , 2006, Bone Marrow Transplantation.
[14] P. Coulie,et al. A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes. , 2002, Cancer research.
[15] J. P. McCoy,et al. In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation. , 2004, Blood.
[16] Danielle W. Lu,et al. Detecting the expression of human endogenous retrovirus E envelope transcripts in human prostate adenocarcinoma , 2003, Cancer.
[17] A. Billiau,et al. Experimental and clinical approaches for optimization of the graft-versus-leukemia effect , 2007, Nature Clinical Practice Oncology.
[18] Brian Keith,et al. Hypoxia-Inducible Factors, Stem Cells, and Cancer , 2007, Cell.
[19] L. Hertle,et al. Histologic subtype of metastatic renal cell carcinoma predicts response to combined immunochemotherapy with interleukin 2, interferon alpha and 5-fluorouracil. , 2007, European urology.